Applied DNA Sciences Inc Price to Book Ratio 2010-2024 | APDN
Historical price to book ratio values for Applied DNA Sciences Inc (APDN) over the last 10 years. The current price to book ratio for Applied DNA Sciences Inc as of May 02, 2025 is 0.08.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Applied DNA Sciences Inc Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2025-05-02 | 0.89 | 0.08 | |
| 2024-12-31 | 10.20 | $11.60 | 0.88 |
| 2024-09-30 | 32.49 | $43.48 | 0.75 |
| 2024-06-30 | 20.42 | $59.40 | 0.34 |
| 2024-03-31 | 410.00 | $-10.16 | -40.35 |
| 2023-12-31 | 616.80 | $302.25 | 2.04 |
| 2023-09-30 | 1210.00 | $356.73 | 3.39 |
| 2023-06-30 | 1290.00 | $557.29 | 2.31 |
| 2023-03-31 | 1130.00 | $772.19 | 1.46 |
| 2022-12-31 | 1660.00 | $709.46 | 2.34 |
| 2022-09-30 | 1130.00 | $1,000.00 | 1.13 |
| 2022-06-30 | 738.20 | $756.40 | 0.98 |
| 2022-03-31 | 2140.00 | $928.65 | 2.30 |
| 2021-12-31 | 4020.00 | $1,121.02 | 3.59 |
| 2021-09-30 | 5390.00 | $1,484.50 | 3.63 |
| 2021-06-30 | 6790.00 | $2,081.71 | 3.26 |
| 2021-03-31 | 7190.00 | $2,487.31 | 2.89 |
| 2020-12-31 | 5100.00 | $1,010.94 | 5.04 |
| 2020-09-30 | 7730.00 | $1,110.15 | 6.96 |
| 2020-06-30 | 8070.00 | $1,767.06 | 4.57 |
| 2020-03-31 | 4020.00 | $1,790.34 | 2.25 |
| 2019-12-31 | 4190.00 | $2,072.96 | 2.02 |
| 2019-09-30 | 8940.00 | $-0.70 | -12715.12 |
| 2019-06-30 | 20000.00 | $-0.05 | -428265.52 |
| 2019-03-31 | 28500.00 | $-0.02 | -1461538.86 |
| 2018-12-31 | 16000.00 | $0.02 | 744185.86 |
| 2018-09-30 | 59600.00 | $1.00 | 59403.97 |
| 2018-06-30 | 50400.00 | $0.10 | 495575.22 |
| 2018-03-31 | 57600.00 | $0.19 | 303637.32 |
| 2017-12-31 | 63600.00 | $0.27 | 235120.15 |
| 2017-09-30 | 114800.00 | $0.25 | 457735.25 |
| 2017-06-30 | 70400.00 | $0.29 | 240109.14 |
| 2017-03-31 | 66000.00 | $0.35 | 187021.82 |
| 2016-12-31 | 74000.00 | $0.46 | 159896.28 |
| 2016-09-30 | 122000.00 | $0.43 | 283128.34 |
| 2016-06-30 | 129200.00 | $0.51 | 255033.56 |
| 2016-03-31 | 137600.00 | $0.62 | 220230.40 |
| 2015-12-31 | 129600.00 | $0.75 | 173192.57 |
| 2015-09-30 | 204800.00 | $0.59 | 350085.39 |
| 2015-06-30 | 124000.00 | $0.58 | 212875.60 |
| 2015-03-31 | 103600.00 | $0.11 | 919254.66 |
| 2014-12-31 | 115600.00 | $0.19 | 607461.70 |
| 2014-09-30 | 218399.00 | $-0.11 | -2070134.48 |
| 2014-06-30 | 293039.00 | $0.00 | 732597031.25 |
| 2014-03-31 | 302399.00 | $0.00 | -755997578.13 |
| 2013-12-31 | 390479.00 | $0.00 | 169773288.04 |
| 2013-09-30 | 215999.00 | $0.35 | 612763.52 |
| 2013-06-30 | 479998.00 | $0.00 | 154838094.76 |
| 2013-03-31 | 549598.00 | $-0.01 | -99926875.00 |
| 2012-12-31 | 503998.00 | $-0.01 | -49411577.82 |
| 2012-09-30 | 609598.00 | $0.00 | 507998177.08 |
| 2012-06-30 | 120000.00 | $0.00 | 57142641.37 |
| 2012-03-31 | 142799.00 | $0.00 | 101999620.54 |
| 2011-12-31 | 143999.00 | $0.00 | -55384387.02 |
| 2011-09-30 | 132000.00 | $0.00 | -62856912.20 |
| 2011-06-30 | 143759.00 | $-0.01 | -12722075.50 |
| 2011-03-31 | 136799.00 | $-0.01 | -22799908.85 |
| 2010-12-31 | 134400.00 | $-0.01 | -25846060.70 |
| 2010-09-30 | 110400.00 | $0.00 | -23999901.49 |
| 2010-06-30 | 139199.00 | $-0.01 | -18559929.17 |
| 2010-03-31 | 167999.00 | $-0.01 | -15999943.45 |
| 2009-12-31 | 148799.00 | $-0.01 | -14171376.49 |
| 2009-09-30 | 309599.00 | $-0.01 | -49142703.37 |
| 2009-06-30 | 275999.00 | $0.00 | -78856866.07 |
| 2009-03-31 | 147599.00 | $0.00 | -184499218.75 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Industrial Products | PROTECTION-SFTY | $0.001B | $0.003B |
| Applied DNA Sciences, Inc. provides proprietary DNA-embedded biotechnology security solutions, using non-human DNA, that verify authenticity and protect corporate and government agencies from counterfeiting, fraud, piracy, product diversion, identity theft and unauthorized intrusion. They develop, market, and sub-license DNA security systems, supply-chain management systems and anti-counterfeit solutions. Applied DNA Sciences has an exclusive licensing and partnership agreement covering North America and Europe with Biowell Technology, Inc. of Taiwan. | |||